Dak Prescott says it's the best wide receiver duo he's played with in Dallas. Whether or not Jerry Jones pays up to keep it ...
Novo Nordisk is paying $240 million up front for global rights to zaltenibart, an Omeros drug that blocks the MASP-3 protein to treat diseases caused by excessive activity of the complement system.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback